About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-EDN1,-lacZ)9Mhus
transgene insertion 9, Mansoor Husain
MGI:4837732
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Mc1rtm1.1Mymi/Mc1rtm1.1Mymi
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Tg(Tyr-cre/ERT2)13Bos/0
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB MGI:6269451
cn2
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
involves: C57BL/6J * FVB MGI:6269409
cn3
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Tg(Tyr-cre/ERT2)13Bos/0
involves: C57BL/6J * FVB MGI:6269417
cx4
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
involves: C57BL/6 * CBA MGI:4837876


Genotype
MGI:6269451
cn1
Allelic
Composition
Mc1rtm1.1Mymi/Mc1rtm1.1Mymi
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Tg(Tyr-cre/ERT2)13Bos/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mc1rtm1.1Mymi mutation (1 available); any Mc1r mutation (43 available)
Tg(KRT14-rtTA)F42Efu mutation (1 available)
Tg(tetO-EDN1,-lacZ)9Mhus mutation (1 available)
Tg(Tyr-cre/ERT2)13Bos mutation (12 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation
• following wounding, mice show a significant increase of epidermal melanocytes containing dark pigment in the wound site, indicating that Edn1 overexpression in epithelial cells can rescue the defect of epidermal melanocyte regeneration caused by MC1R loss in the melanocyte lineage

integument
• following wounding, mice show a significant increase of epidermal melanocytes containing dark pigment in the wound site, indicating that Edn1 overexpression in epithelial cells can rescue the defect of epidermal melanocyte regeneration caused by MC1R loss in the melanocyte lineage




Genotype
MGI:6269409
cn2
Allelic
Composition
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Genetic
Background
involves: C57BL/6J * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT14-rtTA)F42Efu mutation (1 available)
Tg(tetO-EDN1,-lacZ)9Mhus mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation
N
• following induction of Edn1 expression with Dox treatment during anagen, mice exhibit no premature hair graying phenotype at least by the 4th telogen
• following induction with Dox during anagen, mice continue to have Tyr+ melanocytes in the melanocyte stem cell (McSC) niche by anagen IV, unlike control mice where Tyr immunoreactivity is reduced after departure of differentiated melanocytes toward the hair bulb, indicating increased differentiation of McSCs during hair follicle regeneration
• however, the number of McSCs is maintained at least by the 4th telogen
• following induction with Dox during anagen, mice show a significant increase in McSC proliferation at anagen onset (anagen I/II) but not at later anagen stages (IV/V); only McSCs with nuclear beta-catenin signal (indicating Wnt activation) show increased proliferation activity at anagen onset
• following Dox treatment immediately after wounding at 8 weeks of age, McSCs found in the bulge, upper hair follicle, and inter-follicular epidermis show significantly higher proliferation activity than those in control mice; after injury, actively proliferating melanocytes express nuclear beta-catenin, whereas cells lacking Wnt activation show no proliferation
• following induction with Dox treatment during anagen, mice show ectopic pigmentation in the bulge/secondary hair germ (sHG) area of hair follicles at anagen onset (anagen I/II), whereas control mice lack pigmentation in this area
• ectopic pigmentation persists in this niche through later stages of anagen
• following Dox treatment immediately after wounding at 8 weeks of age, mice show a dramatic increase of epidermal melanocyte number in the wound area at day 8 after re- epithelialization relative to control mice; unexpectedly, all de novo hair follicles produce pigmented hair, unlike in control mice
• unwounded adult mice treated with Dox during anagen show a significant increase of pigmented melanocytes in interfollicular epidermis by 12 days after induction, indicating enhanced upward migration of McSCs from the hair follicle to the epidermis in the absence of wounding; in contrast, upon induction with Dox during telogen epidermal melanocytes remain undetectable

integument
• following induction with Dox treatment during anagen, mice show ectopic pigmentation in the bulge/secondary hair germ (sHG) area of hair follicles at anagen onset (anagen I/II), whereas control mice lack pigmentation in this area
• ectopic pigmentation persists in this niche through later stages of anagen
• following Dox treatment immediately after wounding at 8 weeks of age, mice show a dramatic increase of epidermal melanocyte number in the wound area at day 8 after re- epithelialization relative to control mice; unexpectedly, all de novo hair follicles produce pigmented hair, unlike in control mice
• unwounded adult mice treated with Dox during anagen show a significant increase of pigmented melanocytes in interfollicular epidermis by 12 days after induction, indicating enhanced upward migration of McSCs from the hair follicle to the epidermis in the absence of wounding; in contrast, upon induction with Dox during telogen epidermal melanocytes remain undetectable

cellular
• following induction with Dox during anagen, mice continue to have Tyr+ melanocytes in the melanocyte stem cell (McSC) niche by anagen IV, unlike control mice where Tyr immunoreactivity is reduced after departure of differentiated melanocytes toward the hair bulb, indicating increased differentiation of McSCs during hair follicle regeneration
• however, the number of McSCs is maintained at least by the 4th telogen
• following induction with Dox during anagen, mice show a significant increase in McSC proliferation at anagen onset (anagen I/II) but not at later anagen stages (IV/V); only McSCs with nuclear beta-catenin signal (indicating Wnt activation) show increased proliferation activity at anagen onset
• following Dox treatment immediately after wounding at 8 weeks of age, McSCs found in the bulge, upper hair follicle, and inter-follicular epidermis show significantly higher proliferation activity than those in control mice; after injury, actively proliferating melanocytes express nuclear beta-catenin, whereas cells lacking Wnt activation show no proliferation




Genotype
MGI:6269417
cn3
Allelic
Composition
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(KRT14-rtTA)F42Efu/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Tg(Tyr-cre/ERT2)13Bos/0
Genetic
Background
involves: C57BL/6J * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctnnb1tm2Kem mutation (1 available); any Ctnnb1 mutation (49 available)
Tg(KRT14-rtTA)F42Efu mutation (1 available)
Tg(tetO-EDN1,-lacZ)9Mhus mutation (1 available)
Tg(Tyr-cre/ERT2)13Bos mutation (12 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation
• following depletion of beta-catenin in McSCs during anagen, McSCs fail to differentiate as shown by the absence of pigment and Tyr expression in McSCs at anagen onset
• following depletion of beta-catenin in McSCs during anagen, McSCs fail to proliferate as shown by the absence of Ki67 expression in McSCs at anagen onset; this is in contrast to control littermates that overexpress Edn1 with intact Wnt signaling
• following depletion of beta-catenin in McSCs during anagen, mice develop a hair-graying phenotype by the 2nd telogen; this is in contrast to control littermates that overexpress Edn1 with intact Wnt signaling
• following depletion of beta-catenin in McSCs during anagen, wounded mice show a significant reduction in the number of epidermal melanocytes relative to control littermates that overexpress Edn1 with intact Wnt signaling

integument
• following depletion of beta-catenin in McSCs during anagen, mice develop a hair-graying phenotype by the 2nd telogen; this is in contrast to control littermates that overexpress Edn1 with intact Wnt signaling
• following depletion of beta-catenin in McSCs during anagen, wounded mice show a significant reduction in the number of epidermal melanocytes relative to control littermates that overexpress Edn1 with intact Wnt signaling

cellular
• following depletion of beta-catenin in McSCs during anagen, McSCs fail to differentiate as shown by the absence of pigment and Tyr expression in McSCs at anagen onset
• following depletion of beta-catenin in McSCs during anagen, McSCs fail to proliferate as shown by the absence of Ki67 expression in McSCs at anagen onset; this is in contrast to control littermates that overexpress Edn1 with intact Wnt signaling




Genotype
MGI:4837876
cx4
Allelic
Composition
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-EDN1,-lacZ)9Mhus/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Myh6-tTA)6Smbf mutation (4 available)
Tg(tetO-EDN1,-lacZ)9Mhus mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• within 8 weeks of doxycycline withdrawal more than half of mice die
• however, mice fed doxycycline exhibit normal survival
• fewer than expected mice are generated indicating fetal loss
• however, treatment with doxycycline restores normal survival

cardiovascular system
N
• after doxycycline withdrawal, mice do not exhibit bradyarrhythmias or tachyarrhythmias
• after doxycycline withdrawal
• after doxycycline withdrawal
• after doxycycline withdrawal, cardiomyocytes contain vesiculated nuclei unlike in wild-type cells
• after doxycycline withdrawal
• after doxycycline withdrawal
• after doxycycline withdrawal, left ventricular endocardial circumference is increased compared to in wild-type mice
• after doxycycline withdrawal
• mild after doxycycline withdrawal
• 5 weeks after doxycycline withdrawal
• after doxycycline withdrawal
• lengthened progressively over time after doxycycline withdrawal
• 5 weeks after doxycycline withdrawal
• after doxycycline withdrawal

behavior/neurological
• 5 weeks after doxycycline withdrawal
• 5 weeks after doxycycline withdrawal

respiratory system
• after doxycycline withdrawal
• 5 weeks after doxycycline withdrawal

liver/biliary system
• after doxycycline withdrawal

muscle
• after doxycycline withdrawal, cardiomyocytes contain vesiculated nuclei unlike in wild-type cells
• after doxycycline withdrawal
• after doxycycline withdrawal

immune system
• after doxycycline withdrawal

growth/size/body
• after doxycycline withdrawal

cellular
• after doxycycline withdrawal





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory